Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

The gluco-regulatory role and mechanism of glucagon action in the dorsal vagal complex

FY 2013-14

Summary
The incidence of diabetes and obesity is reaching epidemic proportions worldwide. This ever-increasing statistic is a sign of the growing need for effective diabetes treatments. A hallmark feature of obesity and diabetes is chronically elevated blood glucose levels, or hyperglycemia. Increased glucose production from the liver leads to hyperglycemia, which causes many of the health complications associated with obesity and diabetes. Thus, lowering glucose production is an important goal in diabetes research. Insulin is a hormone used to treat diabetic patients because it lowers blood glucose in part by reducing liver glucose production. Glucagon counteracts the actions of insulin by increasing the production of glucose, which is then released from the liver into the bloodstream. Recently, my lab revealed a surprising role of glucagon action in the brain. It was demonstrated that an infusion of glucagon directly into the hypothalamus suppresses glucose production. Not only does this oppose the hormone’s classical action, but the effects of glucagon in the brain may also not be limited to the hypothalamus. In the brainstem, a region called the dorsal vagal complex (DVC) responds to various hormonal signals to regulate blood glucose levels, and so the question arises whether glucagon acts in this brain region as well. The proposed research will use rodent models to examine the role of DVC glucagon in controlling glucose production and the cellular mechanism through which this occurs. My preliminary results indicate that, like in the hypothalamus, glucagon in the DVC also suppresses glucose production from the liver. I will use chemical and molecular treatments that inhibit parts of the hypothesized pathway to identify which molecules are involved in glucagon’s action in the DVC. The anticipated findings of this project have the potential to unveil glucagon action in the DVC as a target for therapeutic strategies in lowering blood glucose levels in diabetes/obesity.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
311731
Name
LaPierre Mary
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The gluco-regulatory role and mechanism of glucagon action in the dorsal vagal complex
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Diabetes; Dorsal Vagal Complex; Energy Homeostasis; Glucagon; Glucose; Obesity
Abstract
The incidence of diabetes and obesity is reaching epidemic proportions worldwide. This ever-increasing statistic is a sign of the growing need for effective diabetes treatments. A hallmark feature of obesity and diabetes is chronically elevated blood glucose levels, or hyperglycemia. Increased glucose production from the liver leads to hyperglycemia, which causes many of the health complications associated with obesity and diabetes. Thus, lowering glucose production is an important goal in diabetes research. Insulin is a hormone used to treat diabetic patients because it lowers blood glucose in part by reducing liver glucose production. Glucagon counteracts the actions of insulin by increasing the production of glucose, which is then released from the liver into the bloodstream. Recently, my lab revealed a surprising role of glucagon action in the brain. It was demonstrated that an infusion of glucagon directly into the hypothalamus suppresses glucose production. Not only does this oppose the hormone’s classical action, but the effects of glucagon in the brain may also not be limited to the hypothalamus. In the brainstem, a region called the dorsal vagal complex (DVC) responds to various hormonal signals to regulate blood glucose levels, and so the question arises whether glucagon acts in this brain region as well. The proposed research will use rodent models to examine the role of DVC glucagon in controlling glucose production and the cellular mechanism through which this occurs. My preliminary results indicate that, like in the hypothalamus, glucagon in the DVC also suppresses glucose production from the liver. I will use chemical and molecular treatments that inhibit parts of the hypothesized pathway to identify which molecules are involved in glucagon’s action in the DVC. The anticipated findings of this project have the potential to unveil glucagon action in the DVC as a target for therapeutic strategies in lowering blood glucose levels in diabetes/obesity.
Competitiondate
201312
Approvedterm2
1 yr 0 mth
Pinamesdelim
LaPierre, Mary
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~